Reta results in clinical trials show up to 24% weight loss at 48 weeks. See reta before and after timelines, dose data, side effects, and safety facts.
Reta results generally refer to the weight loss seen with retatrutide, an investigational triple-agonist peptide that targets GLP-1, GIP, and glucagon receptors at the same time. In the Phase 2 trial published in the New England Journal of Medicine, adults with obesity lost an average of about 24% of their body weight after 48 weeks on the highest dose, compared with roughly 2% on placebo. Retatrutide is not FDA-approved for human use, so every credible result today comes from controlled research rather than a consumer product.
What Counts as a Real Reta Result
In trials, researchers measure results with specific endpoints instead of photos or single-day scale readings. That distinction matters when you compare online claims with published data.
- Percent body weight lost — the primary obesity endpoint in retatrutide trials
- Waist circumference — a marker of visceral fat reduction
- Blood sugar and A1c — tracked in participants with type 2 diabetes
- Body composition — how much of the loss came from fat versus lean mass
- Discontinuation rate — how many people stopped because of side effects
A reported reta result is only meaningful when it includes the dose, the treatment duration, and the starting body weight.
Reta Results by Dose in the Phase 2 Trial
The Phase 2 study randomized adults with obesity but without diabetes to weekly retatrutide or placebo for 48 weeks. Weight loss scaled with dose, and so did gastrointestinal side effects.
| Weekly dose | Average weight loss at 48 weeks | What it suggests |
|---|---|---|
| Placebo | About 2% | Baseline for comparison |
| 1 mg | About 9% | Low-dose response |
| 4 mg | About 17% | Mid-range response |
| 8 mg | About 23% | Near-maximal response |
| 12 mg | About 24% | Highest average loss reported |
Higher retatrutide doses produced greater average weight loss in the Phase 2 trial, but they also produced more nausea, vomiting, and treatment discontinuations. These averages describe groups, not individuals, and some participants lost far more or far less than the mean.
Reta Before and After: What the Timeline Looks Like
Reta before and after timelines reported in trials and in patient anecdotes follow a fairly predictable pattern, because the drug is titrated upward slowly to limit side effects.
- Weeks 1–2: Appetite often drops first, before any meaningful change on the scale.
- Month 1: Early reta before and after 1 month comparisons usually show modest loss, often a few pounds, plus reduced food cravings.
- Months 3–4: Weight loss accelerates as the dose reaches a maintenance level, and clothing sizes start changing.
- Months 6–12: The largest changes appear here, with average losses in the double digits at higher doses.
Most of the weight loss in the Phase 2 trial accumulated over the full 48 weeks rather than in the first few months. Anyone judging reta results after four weeks is looking at the earliest and least impressive part of the curve.
Reta Before and After for Men, Women, and Facial Changes
Published trial data does not show a large difference in percent weight loss between men and women, though starting weight, body composition, and dose escalation can shift individual outcomes. Reta results for men and reta results for women are usually compared in online threads using photos rather than measured endpoints, which makes those comparisons unreliable.
One visible change does show up consistently in larger weight loss: reduced facial volume. Rapid fat loss can make the face look thinner and older before the rest of the body catches up. A reta before and after face comparison often reflects overall fat loss rather than anything specific to the peptide.
Reta Reviews, Reddit Threads, and Blends
Search reta reviews and you will find a mix of trial summaries, personal logs, and vendor marketing. Reddit threads can be useful for understanding day-to-day side effects, but they are not evidence of how well the drug works. Self-reported posts also rarely include dose, duration, or lab work.
Some people searching for where to inject reta for best results are really asking about subcutaneous injection technique and rotation sites, which is a question for a clinician — not a forum. Others end up comparing unrelated compounds, and a search for aod-9604 results reddit leads to a fragment of growth hormone with much weaker evidence behind it.
Stacking is common in peptide communities. People who track cjc-1295 ipamorelin results before and after are usually chasing recovery and body composition goals rather than appetite suppression, and that is a different mechanism entirely from a triple agonist.
Combination products marketed as a cagri reta blend benefits pitch are also worth treating with caution. A cagri reta blend side effects profile has not been characterized in large human trials, and mixing unapproved peptides increases the chance of an unexpected reaction.
Side Effects, Safety, and the Bottom Line
The most common retatrutide side effects in trials were nausea, diarrhea, vomiting, and constipation, and they were usually worst during dose increases. Researchers also monitored heart rate, gallbladder events, and injection-site reactions.
Retatrutide is an investigational drug, and it is not approved by the FDA for weight loss or any other indication in the United States. Products sold online as "reta" are typically research chemicals labeled not for human consumption, which means purity, dosing, and sterility are not guaranteed.
Anyone considering a GLP-1–type medication should talk with a licensed healthcare professional about approved options, personal risk factors, and monitoring. A trial result from a controlled study cannot predict how one individual will respond to an unverified vial.
Frequently Asked Questions
How much weight loss do reta results show in clinical trials?
In the Phase 2 retatrutide trial, participants with obesity lost an average of about 24% of their body weight at 48 weeks on the highest 12 mg weekly dose, compared with roughly 2% on placebo. Lower doses produced smaller average losses, ranging from about 9% to 23%. Individual results varied widely, and retatrutide is not FDA-approved for human use.
How long does it take to see results from retatrutide?
Appetite changes often appear within the first one to two weeks, while measurable weight loss is usually clearer by four to eight weeks. Because the dose is increased gradually, most of the total weight loss accumulates over six to twelve months. Judging results after one month tends to understate the eventual outcome.
Is retatrutide legally available in the United States?
No. Retatrutide remains an investigational drug and is only legally accessible through registered clinical trials. Products sold online as "reta" are generally research chemicals labeled not for human consumption, so their purity, dosing accuracy, and sterility are unverified. Talk with a healthcare professional about approved alternatives.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.